Oska Health has raised $11.0 million in new investment capital to advance its digital-first approach to chronic kidney disease (CKD) management. The funding round underscores investor confidence in Oska Health's mission to combine technology, behavioral science, and health expertise to help individuals affected by CKD and other chronic conditions lead healthier lives.
The company is developing a novel digital platform designed to enhance patient care and support between doctor visits. Oska Health's solution aims to make doctors more efficient and effective during appointments by providing comprehensive patient data. Crucially, it offers continuous support for health issues and assists patients in adjusting their lifestyles, making support readily accessible. This personalized digital program also provides doctors with peace of mind, knowing their patients are consistently supported outside of clinical settings.
This significant capital infusion is expected to accelerate Oska Health's growth initiatives and expand its reach within the chronic care sector. The company plans to use the funds to further develop its technology platform, enhance its patient engagement tools, and scale its operations to serve a broader population of individuals living with chronic kidney disease. The investment will support the expansion of its team and the refinement of its evidence-based programs.
Looking ahead, Oska Health is positioned to strengthen its impact on chronic disease management. The company aims to continue innovating its digital health solutions, ultimately enabling more people to effectively manage their conditions and improve their overall quality of life through accessible and integrated care.
